Oncology

The FDA approved the use of quizartinib for certain patient populations with acute myeloid leukemia in July 2023.

A team of researchers compared the presence of short-term side effects using two image-guided radiation treatment—magnetic resonance imaging-guided daily adaptive prostate stereotactic body radiotherapy...

In a recent study, researchers sought to determine the potential for the overdiagnosis of breast cancer after screening for women 70 years of age and older.

The FDA approval follows a single-arm, multicenter, open-label trial in 91 patients with uveal melanoma with unresectable hepatic metastases.

Researchers reported on the treatment approaches and outcomes of patients with T‑cell prolymphocytic leukemia after allogeneic transplant in a multicenter, retrospective study.

Researchers set out to determine how momelotinib impacts patients’ overall transfusion burden.

Researchers set out to determine whether cancer-related cognitive impairment impacts older adults with acute myeloid leukemia treated with hypomethylating agents and venetoclax chemotherapy.

Metastatic uveal melanoma has been a difficult condition to treat due to a lack of effective treatment options. Authors of a recent review aimed to determine the benefit of immune checkpoint inhibition...

In their presentation at the 48th ONS Congress, in San Antonio, Texas, Denise Nicholson BSN, RN and Colleen Nevins DNP, RN, CNE describe the best practices for advance care planning conversations and review...

In her presentation at the 48th ONS Congress, in San Antonio, Texas, Gayle Somerstein, RN, OCN, BSN, MPH, MBA, reviews common adult learning styles that can be tailored to each patient’s individualized...